Drammen sykehus Vestre Viken HF

Drammen N-3004

2 studies enrolling now · 5 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Diabetes Mellitus, Type 2, Ischemic Stroke, Neoplasm Metastasis, Obesity, Overweight, Stroke, Acute

Studies at this site

• Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer — Recruiting now
• A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer — Recruiting now
• Weight Loss in People Living With Overweight or Obesity Following Treatment With Cagrilintide — Running, not enrolling
• A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin Icodec — Completed
• Tenecteplase in Wake-up Ischaemic Stroke Trial — Status unconfirmed